From: Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
Variables
Case (n)
Visfatin (ng/mL)
control group
55
6.74 (5.76,7.53)
Single vessel coronary lesions
70
7.68 (6.37,9.65)*
Double vessel coronary lesions
57
7.67 (6.66,8.92)*
Multiple vessel coronary lesions
56
8.14 (6.63,11.60)*